MR
$47.03
+0.15
(+0.32%)
As of May 26, 2026, 8:57 PM EDT
Moderna (MRNA) is trading up at $47.03 (+0.32%) on NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
IPO: December 7, 2018 · $23.00 offering · NASDAQ · View IPO details →
About Moderna
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
Recent News (2)
-
Moderna’s mRNA flu shot to get FDA review Presented by Coalition to Strengthen America’s Healthcare {beacon} Health Care Health Care The Big Story Moderna’s mRNA flu shot to get FDA review After some initial back-and-forth, Moderna’s candid…
-
Moderna mRNA flu vaccine to get FDA panel review Moderna’s experimental mRNA flu shot will be reviewed by a Food and Drug Administration (FDA) advisory panel next month, a move that suggests a more stable approach to drug reviews after the firing of…